Stocks · Health care · Services-Medical Laboratories

CareDx, Inc.

CDNA Clue Score46
United States Fiscal year ends December CIK 0001217234 Results filed 29 Oct 2026

What the insiders did Net selling

By person

32 insiders · 366 transactions
44.0×

John W. Hanna holds 44.0 times base salary in stock. $30.55M of shares against $693.27K in salary for 2025.

Salary from the company's own proxy. The shares are what John W. Hanna last reported holding, valued at $46.75, the price Common Stock was last bought or sold at on the open market here, on 5 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Peter Maag
Director
$1.09K (3)
$46.78M (110) scheduled
−$46.78M
309,846
0.5989%
$14.49M
+21.2%
Michael Goldberg
Director
—
$10.86M (22)
−$10.86M
153,371
0.2965%
$7.17M
+130.9%
Reginald Seeto
See Remarks
—
$9.41M (45) scheduled
−$9.41M
479,164
0.9262%
$22.40M
+23,668%
Sasha King
Chief Marketing Officer
—
$8.50M (19) scheduled
−$8.50M
78,420
0.1516%
$3.67M
+104.8%
John Walter Hanna JR
President and CEO
—
$7.54M (11) scheduled
−$7.54M
644,937
1.25%
$30.15M
+32.2%
Michael Brian Bell
Chief Financial Officer
$1.32K (2)
$6.15M (11) scheduled
−$6.15M
103,343
0.1998%
$4.83M
+2,581%
George Bickerstaff
Director
—
$4.65M (11)
−$4.65M
134,061
0.2591%
$6.27M
+677.8%
William A Hagstrom
Director
—
$3.74M (9) scheduled
−$3.74M
53,979
0.1043%
$2.52M
+255.4%
Alexander L Johnson
See Remarks
—
$3.16M (5) scheduled
−$3.16M
284,983
0.5509%
$13.32M
+39.9%
James P Yee
Chief Medical Officer
—
$2.71M (5) scheduled
−$2.71M
42,045
0.0813%
$1.97M
+30.8%
Neil Gagnon
10% owner
$646.33K (30)
$2.94M (2)
−$2.29M
2,048,465
3.96%
$95.77M
+4.8%
Ralph Snyderman
Director
—
$1.83M (5)
−$1.83M
58,177
0.1125%
$2.72M
+459.2%
Hannah Valantine
Director
—
$1.52M (4) scheduled
−$1.52M
36,686
0.0709%
$1.72M
—
Christine Cournoyer
Director
—
$1.45M (3) scheduled
−$1.45M
42,943
0.0830%
$2.01M
—
Jeffrey Adam Novack
Secretary and General Counsel
—
$824.51K (17) scheduled
−$824.51K
102,205
0.1976%
$4.78M
−19.5%
Mitchell J Nelles
Chief Operating Officer
—
$573.40K (2) scheduled
−$573.40K
86,889
0.1680%
$4.06M
+37.3%
Grace Colon
Director
—
$229.86K (3)
−$229.86K
23,708
0.0458%
$1.11M
—
Ankur Dhingra
Chief Financial Officer
$211.69K (1)
—
+$211.69K
38,146
0.0737%
$1.78M
—
Arthur A Torres
Director
$28.57K (1)
$214.68K (2)
−$186.10K
38,665
0.0747%
$1.81M
—
Abhishek Jain
Chief Financial Officer
—
$4.70K (1)
−$4.70K
319,725
0.6180%
$14.95M
+69.8%
Abraham Ronai
See Remarks
—
—
—
515,986
0.9974%
$24.12M
+662.7%
Keith Kennedy
CFO & COO
—
—
—
208,686
0.4034%
$9.76M
+15,879%
Jessica Meng
Chief Commercial Officer
—
—
—
158,980
0.3073%
$7.43M
+12,073%
Fred E Cohen
Director
—
—
—
140,060
0.2707%
$6.55M
+628.0%
Nathan Smith
Chief Financial Officer
—
—
—
79,016
0.1527%
$3.69M
—
Richard Bryan Riggsbee
Director
—
—
—
39,312
0.0760%
$1.84M
—
Suresh Gunasekaran
Director
—
—
—
37,248
0.0720%
$1.74M
—
John Joseph Sninsky
Chief Scientific Officer
—
—
—
22,309
0.0431%
$1.04M
+59.4%
Douglas S Miller
Director
—
—
—
17,695
0.0342%
$827.24K
+53.2%
Amy Abernethy
Director
—
—
—
15,837
0.0306%
$740.38K
—
Charles Constanti
Chief Financial Officer
—
—
—
10,000
0.0193%
$467.50K
—
Anders Karlsson
Chief Commercial Officer
—
—
—
9,638
0.0186%
$450.58K
—